$200M And Partnering With Glaxo and Johnson & Johnson

Index Ventures may be best known on these pages for its research investments, nevertheless today it launched a new fund that points to how the company is willing to put its money into other examples of strong technology. The life sciences fund will see Index put in $100 million of its own capital, and have it matched by $50 million each from big pharma leaders GlaxoSmithKline and Johnson & Johnson.

Index Ventures is a leading venture capital firm specializing in investments in information research and life sciences companies. The firm invests in seed, early and growth stage start-ups across US and Europe.Since its inception in 1996, Index Ventures has backed visionary entrepreneurs who have taken on incumbents and built seminal companies in a number of growth sectors including: open source software companies just as MySQL, Trolltech, Zend and Pentaho; broadband and VoIP (Voice over Internet Protocol) companies just as Virata, Skype, FON and...